MicroRNAs in the bile of patients with biliary strictures after liver transplantation

Tim O Lankisch1, Torsten Voigtländer, Michael P Manns

  • 1Department of Gastroenterology, Hepatology, and Endocrinology, Hannover Medical School, Hannover, Germany; Integrated Research and Treatment Center-Transplantation, Hannover Medical School, Hannover, Germany.

Insights

Specific microRNAs (miRNAs) in bile, including miR-517a, miR-892a, and miR-106a*, are elevated in liver transplant patients with ischemic-type biliary lesions (ITBLs). This finding may aid in diagnosing ITBLs, a common complication after liver transplantation.

Area of Science:

  • Hepatology
  • Transplantation immunology
  • Molecular diagnostics

Background:

  • Biliary complications, particularly ischemic-type biliary lesions (ITBLs), significantly impact morbidity and graft survival after liver transplantation.
  • The underlying mechanisms of ITBLs are not fully understood, and effective diagnostic markers are lacking.
  • MicroRNA (miRNA) profiling in bile presents a promising avenue for identifying biomarkers in hepatobiliary diseases.

Purpose of the Study:

  • To identify specific miRNA patterns in bile that distinguish ITBLs from other biliary complications post-liver transplantation.
  • To evaluate the potential of these miRNAs as diagnostic markers for ITBLs.

Main Methods:

  • A cross-sectional study involving liver transplant patients with biliary complications: ITBLs (n=37), anastomotic strictures (ASs; n=39), and bile duct stones (BDSs; n=12).
  • Global miRNA profiling of bile samples followed by polymerase chain reaction (PCR)-mediated validation for specific miRNAs.
  • Analysis of miRNA concentrations based on ITBL severity (intrahepatic and extrahepatic strictures).

Main Results:

  • Concentrations of miR-517a, miR-892a, and miR-106a* were significantly increased in the bile of patients with ITBLs compared to those with ASs or BDSs (P < 0.05).
  • Higher median concentrations of these miRNAs were observed in patients with intrahepatic and extrahepatic ITBL strictures, though not statistically significant (P > 0.05).
  • No significant differences were found for miR-210, miR-337-5p, miR-577, and miR-329 between groups.

Conclusions:

  • miR-517a, miR-892a, and miR-106a* are elevated in bile from liver transplant recipients with ITBLs, differentiating them from ASs and BDSs.
  • miRNA profiling in bile holds potential for the diagnosis and management of ITBLs.
  • Further research is warranted to confirm the prognostic value of these identified miRNAs in ITBLs.